BioRestorative Therapies, Inc., a pioneering clinical-stage company specializing in stem cell-based therapies, has achieved a significant milestone in its quest to combat obesity and metabolic disorders.
The United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the company’s ThermoStem® program. This development, announced on December 12, 2023, marks the fourth U.S. patent granted under this patent family.
The upcoming patent, scheduled to be issued as U.S. Patent No. 11,851,682 on December 26, 2023, encompasses methods for using differentiated human brown fat adipocytes. These are crucial in screening and identifying compounds that can activate and regulate metabolic activity, potentially leading to effective weight loss drugs. The therapeutic benefits of activated brown adipose tissue have been demonstrated in various models, showing promise in treating a range of metabolic disorders, including type 2 diabetes.
Lance Alstodt, CEO of BioRestorative, highlighted the importance of this allowance, noting its role in providing advanced tools for screening compounds targeting metabolic disorders like obesity. This patent will enable the company to allocate resources towards developing these valuable tools.
BioRestorative Therapies is renowned for its innovative approaches in cell and tissue protocols, primarily involving adult stem cells. Their two core programs include the brtxDISC™ for treating disc/spine disease and the ThermoStem® program for targeting obesity and metabolic disorders. The latter involves using brown adipose-derived stem cells to generate brown adipose tissue (BAT), which plays a key role in regulating metabolic homeostasis.
Early research indicates that BAT can contribute to increased caloric burning and reduced glucose and lipid levels, potentially lowering obesity and diabetes risks.
This press release also contains forward-looking statements, cautioning readers about the potential risks and uncertainties that could affect future results.
For more information about BioRestorative Therapies, Inc., visit their website at www.biorestorative.com.